Literature DB >> 33499829

Prehospital arterial hypercapnia in acute heart failure is associated with admission to acute care units and emergency room length of stay: a retrospective cohort study.

Mathias Fabre1, Christophe A Fehlmann2, Birgit Gartner2, Catherine G Zimmermann-Ivoll3, Florian Rey4, François Sarasin2, Laurent Suppan2.   

Abstract

BACKGROUND: Acute Heart Failure (AHF) is a common condition that often presents with acute respiratory distress and requires urgent medical evaluation and treatment. Arterial hypercapnia is common in AHF and has been associated with a higher rate of intubation and non-invasive ventilation in the Emergency Room (ER), but its prognostic value has never been studied in the prehospital setting.
METHODS: A retrospective study was performed on the charts of all patients taken care of by a physician-staffed prehospital mobile unit between June 2016 and September 2019 in Geneva. After approval by the ethics committee, charts were screened to identify all adult patients with a diagnosis of AHF in whom a prehospital arterial blood gas (ABG) sample was drawn. The main predictor was prehospital hypercapnia. The primary outcome was the admission rate in an acute care unit (ACU, composite of intensive care and high-dependency units). Secondary outcomes were ER length of stay (LOS), orientation from ER (intensive care unit, high-dependency unit, general ward, discharge home), intubation rate at 24 h, hospital LOS and hospital mortality.
RESULTS: A total of 106 patients with a diagnosis of AHF were analysed. Hypercapnia was found in 61 (58%) patients and vital signs were more severely altered in this group. The overall ACU admission rate was 48%, with a statistically significant difference between hypercapnic and non-hypercapnic patients (59% vs 33%, p = 0.009). ER LOS was shorter in hypercapnic patients (5.4 h vs 8.9 h, p = 0.016).
CONCLUSIONS: There is a significant association between prehospital arterial hypercapnia, acute care unit admission, and ER LOS in AHF patients.

Entities:  

Keywords:  Acute heart failure; Arterial blood gas; Prehospital

Year:  2021        PMID: 33499829      PMCID: PMC7837504          DOI: 10.1186/s12873-021-00411-9

Source DB:  PubMed          Journal:  BMC Emerg Med        ISSN: 1471-227X


  23 in total

1.  Meta-analysis: Noninvasive ventilation in acute cardiogenic pulmonary edema.

Authors:  Cui-Lian Weng; Yun-Tao Zhao; Qing-Hua Liu; Chang-Jun Fu; Feng Sun; Yan-Liang Ma; Yan-Wen Chen; Quan-Ying He
Journal:  Ann Intern Med       Date:  2010-05-04       Impact factor: 25.391

2.  Acidemia in severe acute cardiogenic pulmonary edema treated with noninvasive pressure support ventilation: a single-center experience.

Authors:  Chiara Lazzeri; Gian F Gensini; Claudio Picariello; Paola Attanà; Alessio Mattesini; Marco Chiostri; Serafina Valente
Journal:  J Cardiovasc Med (Hagerstown)       Date:  2015-09       Impact factor: 2.160

3.  Non-invasive positive pressure ventilation (CPAP or bilevel NPPV) for cardiogenic pulmonary oedema.

Authors:  Nicolas Berbenetz; Yongjun Wang; James Brown; Charlotte Godfrey; Mahmood Ahmad; Flávia Mr Vital; Pier Lambiase; Amitava Banerjee; Ameet Bakhai; Matthew Chong
Journal:  Cochrane Database Syst Rev       Date:  2019-04-05

Review 4.  Noninvasive positive pressure ventilation: effect on mortality in acute cardiogenic pulmonary edema: a pragmatic meta-analysis.

Authors:  Jayson Mathew Potts
Journal:  Pol Arch Med Wewn       Date:  2009-06

Review 5.  Prehospital therapy for acute congestive heart failure: state of the art.

Authors:  Vincent N Mosesso; James Dunford; Thomas Blackwell; John K Griswell
Journal:  Prehosp Emerg Care       Date:  2003 Jan-Mar       Impact factor: 3.077

6.  2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.

Authors:  Piotr Ponikowski; Adriaan A Voors; Stefan D Anker; Héctor Bueno; John G F Cleland; Andrew J S Coats; Volkmar Falk; José Ramón González-Juanatey; Veli-Pekka Harjola; Ewa A Jankowska; Mariell Jessup; Cecilia Linde; Petros Nihoyannopoulos; John T Parissis; Burkert Pieske; Jillian P Riley; Giuseppe M C Rosano; Luis M Ruilope; Frank Ruschitzka; Frans H Rutten; Peter van der Meer
Journal:  Eur Heart J       Date:  2016-05-20       Impact factor: 29.983

Review 7.  Prognostic indicators in patients presenting with acute cardiogenic pulmonary edema treated with CPAP: it's not the acid that matters, it's back to basics.

Authors:  Dominik Schlosshan; Mark Elliott
Journal:  Crit Care       Date:  2010-12-03       Impact factor: 9.097

8.  Hypercapnia in patients with acute heart failure.

Authors:  Masaaki Konishi; Eiichi Akiyama; Hiroyuki Suzuki; Noriaki Iwahashi; Nobuhiko Maejima; Kengo Tsukahara; Kiyoshi Hibi; Masami Kosuge; Toshiaki Ebina; Kentaro Sakamaki; Yasushi Matsuzawa; Mitsuaki Endo; Satoshi Umemura; Kazuo Kimura
Journal:  ESC Heart Fail       Date:  2015-03-25

9.  Diagnostic value of prehospital arterial blood gas measurements - a randomised controlled trial.

Authors:  Stine T Zwisler; Yecatarina Zincuk; Caroline B Bering; Aleksander Zincuk; Mads Nybo; Søren Mikkelsen
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2019-03-18       Impact factor: 2.953

10.  Effect of noninvasive ventilation on intubation risk in prehospital patients with acute cardiogenic pulmonary edema: a retrospective study.

Authors:  Birgit Andrea Gartner; Christophe Fehlmann; Laurent Suppan; Marc Niquille; Olivier T Rutschmann; François Sarasin
Journal:  Eur J Emerg Med       Date:  2020-02       Impact factor: 4.106

View more
  1 in total

1.  Association between prehospital arterial hypercapnia and mortality in acute heart failure: a retrospective cohort study.

Authors:  Mathias Fabre; Christophe A Fehlmann; Kevin E Boczar; Birgit Gartner; Catherine G Zimmermann-Ivol; François Sarasin; Laurent Suppan
Journal:  BMC Emerg Med       Date:  2021-11-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.